All News #Library
Biotech
NLS Pharma Expands CNS Pipeline With Aex-6Xx Series
30 Oct 2025 //
PR NEWSWIRE
NLS and Kadimastem Partner with TargetGene for Cell Therapies
27 Oct 2025 //
PR NEWSWIRE
NLS Pharma and Kadimastem Patent Cell-Selection Tech for IsletRx
04 Sep 2025 //
PR NEWSWIRE
NLS Pharma Notes Progress in iTOL-102 Type 1 Diabetes Study
17 Jul 2025 //
PR NEWSWIRE

Market Place
Sourcing Support